Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Smear Positive Pulmonary Tuberculosis”

Showing 16 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03563599
What this trial is testing

Evaluate Early Bactericidal Activity, Safety, Tolerability, and Pharmacokinetics of Multiple Oral Doses of Telacebec (Q203)

Who this might be right for
Treatment-naïve, Sputum Smear-positive Patients With Drug-sensitive Pulmonary TB
Qurient Co., Ltd. 60
Testing effectiveness (Phase 2)Study completedNCT01785186
What this trial is testing

Evaluation of SQ109, High-dose Rifampicin, and Moxifloxacin in Adults With Smear-positive Pulmonary TB in a MAMS Design

Who this might be right for
Tuberculosis, Pulmonary
Michael Hoelscher 365
Testing effectiveness (Phase 2)Study completedNCT01498419
What this trial is testing

Evaluation of 8 Weeks of Treatment With the Combination of Moxifloxacin, PA-824 and Pyrazinamide in Patients With Drug Sensitive and Multi Drug-Resistant Pulmonary Tuberculosis (TB) (NC-002)

Who this might be right for
Pulmonary Tuberculosis
Global Alliance for TB Drug Development 207
Testing effectiveness (Phase 2)Study completedNCT03959566
What this trial is testing

PanACEA Sutezolid Dose-finding and Combination Evaluation

Who this might be right for
Pulmonary TuberculosisOther Specified Pulmonary Tuberculosis
Michael Hoelscher 75
Testing effectiveness (Phase 2)Study completedNCT01691534
What this trial is testing

Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis With Clofazimine (C)-TMC207 (J)-PA-824 (Pa)-Pyrazinamide (Z)

Who this might be right for
Pulmonary Tuberculosis
Global Alliance for TB Drug Development 105
Testing effectiveness (Phase 2)Study completedNCT04550832
What this trial is testing

PanACEA DElpazolid Dose-finding and COmbination DEvelopment (DECODE)

Who this might be right for
Infections and InfestationsPulmonary Tuberculosis
LigaChem Biosciences, Inc. 76
Not applicableStudy completedNCT02701439
What this trial is testing

SMF to Improve Performance of Microscopy for the Diagnosis of PTB in a High HIV Prevalence Setting

Who this might be right for
Tuberculosis
Epicentre 1,050
Testing effectiveness (Phase 2)Study completedNCT02279875
What this trial is testing

Trial to Evaluate the Efficacy and Safety of Linezolid in Tuberculosis Patients. (LIN-CL001)

Who this might be right for
Pulmonary Tuberculosis
Global Alliance for TB Drug Development 113
Large-scale testing (Phase 3)Study completedNCT00677339
What this trial is testing

L-arginine and Vitamin D Adjunctive Therapy in Pulmonary Tuberculosis (TB)

Who this might be right for
Smear Positive Pulmonary Tuberculosis
Menzies School of Health Research 200
Testing effectiveness (Phase 2)Study completedNCT01215110
What this trial is testing

Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis (TMC207-CL001)

Who this might be right for
Pulmonary Tuberculosis
Global Alliance for TB Drug Development 68
Testing effectiveness (Phase 2)Study completedNCT00449644
What this trial is testing

TMC207-TiDP13-C208: Anti-bacterial Activity, Safety, and Tolerability of TMC207 in Participants With Multi-drug Resistant Mycobacterium Tuberculosis (MDR-TB).

Who this might be right for
Tuberculosis
Janssen Infectious Diseases BVBA 208
Testing effectiveness (Phase 2)Study completedNCT02349841
What this trial is testing

Phase 2 Trial to Evaluate the Early Bactericidal Activity, Safety and Tolerability of Meropenem Plus Amoxycillin/CA and Faropenem Plus Amoxycillin/CA in Adult Patients With Newly Diagnosed Pulmonary Tuberculosis

Who this might be right for
Pulmonary Tuberculosis
TASK Applied Science 46
Testing effectiveness (Phase 2)Study completedNCT00401271
What this trial is testing

Safety, Efficacy and Pharmacokinetics of OPC-67683 in Patients With Pulmonary Tuberculosis

Who this might be right for
Pulmonary Tuberculosis
Otsuka Frankfurt Research Institute GmbH 54
Testing effectiveness (Phase 2)Study completedNCT01392911
What this trial is testing

Safety, Tolerability, Extended Early Bactericidal Activity and PK of Higher Doses Rifampicin in Adults With Pulmonary TB

Who this might be right for
Pulmonary Tuberculosis (TB)
Radboud University Medical Center 128
Large-scale testing (Phase 3)UnknownNCT00698386
What this trial is testing

Efficacy of Oral Zinc Administration as an Adjunct Therapy in New Pulmonary Tuberculosis (Category I) Patients

Who this might be right for
Pulmonary Tuberculosis
Ministry of Science and Technology, India 150
Testing effectiveness (Phase 2)Study completedNCT00910871
What this trial is testing

To Evaluate the Safety, Tolerability, and Efficacy of TMC207 as Part of an Individualized Multi-drug Resistant Tuberculosis (MDR-TB) Treatment Regimen in Participants With Sputum Smear-positive Pulmonary MDR-TB.

Who this might be right for
Tuberculosis
Janssen Infectious Diseases BVBA 241

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation